Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PT-112 + Docetaxel in Advanced Solid Tumors and NSCLC
NCT02884479Phase 2Unknown
- Sponsor
- SciClone Pharmaceuticals (Holdings) Limited
- Start
- Aug 2016
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Imifoplatin in solid tumor (advanced stage), non-small cell lung cancer (NSCLC), sponsored by SciClone Pharmaceuticals (Holdings) Limited. Status: unknown.
02
Drugs
Imifoplatin
03
Conditions
solid tumor (advanced stage)non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02884479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02884479.